Harold J. Ting

1.2k total citations
21 papers, 1.0k citations indexed

About

Harold J. Ting is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Harold J. Ting has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Harold J. Ting's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Cell Adhesion Molecules Research (4 papers) and Silymarin and Mushroom Poisoning (4 papers). Harold J. Ting is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Cell Adhesion Molecules Research (4 papers) and Silymarin and Mushroom Poisoning (4 papers). Harold J. Ting collaborates with scholars based in United States and India. Harold J. Ting's co-authors include Rajesh Agarwal, Gagan Deep, Chapla Agarwal, Fadi T. Khasawneh, Anand Ramteke, Scott I. Simon, Barbara Frederick, Samiha Mateen, Michael W. Graner and Anowar Hussain and has published in prestigious journals such as Circulation Research, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Harold J. Ting

20 papers receiving 999 citations

Peers

Harold J. Ting

IMMUN

PRM

ONCOL

Xuemei Fan China

Kenji Kuwabara Japan

Yunbiao Lu United States

Alexandre Mezentsev Russia

Agnieszka Gomułkiewicz Poland

Jong‐Shiaw Jin Taiwan

Dipak Panigrahy United States

Damiano Cosimo Rigiracciolo Italy

Minglu Liang China

Xuemei Fan China

Harold J. Ting

429 ×0.8

170 ×0.5

122 ×0.7

IMMUN

106 ×0.6

PRM

124 ×1.2

ONCOL

Citations per year, relative to Harold J. Ting Harold J. Ting (= 1×) peers Xuemei Fan

Countries citing papers authored by Harold J. Ting

Since Specialization

Citations

This map shows the geographic impact of Harold J. Ting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold J. Ting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold J. Ting more than expected).

Fields of papers citing papers by Harold J. Ting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold J. Ting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold J. Ting. The network helps show where Harold J. Ting may publish in the future.

Co-authorship network of co-authors of Harold J. Ting

This figure shows the co-authorship network connecting the top 25 collaborators of Harold J. Ting. A scholar is included among the top collaborators of Harold J. Ting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold J. Ting. Harold J. Ting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ting, Harold J., Gagan Deep, Sushil Kumar, et al.. (2016). Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment. Carcinogenesis. 37(6). 589–599. 42 indexed citations

Deep, Gagan, et al.. (2015). Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts. Oncotarget. 6(37). 39594–39606. 22 indexed citations

Ting, Harold J., Gagan Deep, Anil Jain, et al.. (2014). Silibinin prevents prostate cancer cell‐mediated differentiation of naïve fibroblasts into cancer‐associated fibroblast phenotype by targeting TGF β2. Molecular Carcinogenesis. 54(9). 730–741. 39 indexed citations

Ting, Harold J., Gagan Deep, Chapla Agarwal, & Rajesh Agarwal. (2014). The strategies to control prostate cancer by chemoprevention approaches. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 760. 1–15. 39 indexed citations

Deep, Gagan, Anil Jain, Anand Ramteke, et al.. (2014). SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin. Molecular Cancer. 13(1). 37–37. 72 indexed citations

Ting, Harold J., Gagan Deep, & Rajesh Agarwal. (2013). Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer. The AAPS Journal. 15(3). 707–716. 56 indexed citations

Ramteke, Anand, Harold J. Ting, Chapla Agarwal, et al.. (2013). Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Molecular Carcinogenesis. 54(7). 554–565. 322 indexed citations

Murad, John P., et al.. (2012). A novel antibody targeting the ligand binding domain of the thromboxane A2 receptor exhibits antithrombotic properties in vivo. Biochemical and Biophysical Research Communications. 421(3). 456–461. 10 indexed citations

Murad, John P., et al.. (2011). The C-terminal segment of the second extracellular loop of the thromboxane A2 receptor plays an important role in platelet aggregation. Biochemical Pharmacology. 83(1). 88–96. 7 indexed citations

10.

Murad, John P., Harold J. Ting, & Fadi T. Khasawneh. (2011). A Novel Mechanism for Calcium Entry Into Blood Platelets. The FASEB Journal. 25(S1). 1 indexed citations

11.

Murad, John P., et al.. (2011). Mouse transient receptor potential channel 6: Role in hemostasis and thrombogenesis. Biochemical and Biophysical Research Communications. 417(2). 853–856. 30 indexed citations

12.

Murad, John P., et al.. (2011). Characterization of theIn VivoAntiplatelet Activity of the Antihypertensive Agent Losartan. Journal of Cardiovascular Pharmacology and Therapeutics. 17(3). 308–314. 9 indexed citations

13.

Ting, Harold J., et al.. (2011). Thromboxane A₂Receptor. Journal of Cardiovascular Pharmacology and Therapeutics. 17(3). 248–259. 25 indexed citations

14.

Ting, Harold J. & Fadi T. Khasawneh. (2010). Platelet function and Isoprostane biology. Should Isoprostanes be the newest member of the Orphan-ligand family?. Journal of Biomedical Science. 17(1). 24–24. 50 indexed citations

15.

Ting, Harold J. & Fadi T. Khasawneh. (2010). Glybenclamide: An antidiabetic with in vivo antithrombotic activity. European Journal of Pharmacology. 649(1-3). 249–254. 13 indexed citations

16.

Ting, Harold J., Wallace J. Murray, & Fadi T. Khasawneh. (2010). Repurposing an old drug for a new use: glybenclamide exerts antiplatelet activity by interacting with the thromboxane A2 receptor. Acta Pharmacologica Sinica. 31(2). 150–159. 11 indexed citations

17.

Gower, R. Michael, Harold J. Ting, Ulrich Y. Schaff, et al.. (2008). Spatial Regulation of Inflammation by Human Aortic Endothelial Cells in a Linear Gradient of Shear Stress. Microcirculation. 15(4). 311–323. 66 indexed citations

18.

Schaff, Ulrich Y., Melissa R. Sarantos, Harold J. Ting, & Scott I. Simon. (2007). Optical and Fluorescence Detection of Neutrophil Integrin Activation. Methods in molecular biology. 412. 203–210. 1 indexed citations

19.

Sadhu, Chanchal, Harold J. Ting, Brian P. Lipsky, et al.. (2007). CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity. Journal of Leukocyte Biology. 81(6). 1395–1403. 81 indexed citations

20.

Ting, Harold J., James P. Stice, Ulrich Y. Schaff, et al.. (2007). Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-α. Circulation Research. 100(3). 381–390. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact